Abstract
. Diagram of Doppler monitor display. V 1 is the velocity at the distal prostatic urethra (S 1 ); V 2 is the velocity at the membranous urethra (S 2 ); A 1 is the functional crosssectional area (FCSA) which equals Q max /V 1 ; A 2 is the FCSA which equals Q max /V 2 , and VR is the velocity ratio which equals V 1 /V 2 . Bladder Bladder dynamic component of obstruction [3, 4] . However, 15-20% of patients do not show any improvement [5, 6] . Some investigators consider assessment of pressure flow changes mandatory to evaluate the effects of medical therapy [7] . Others consider urodynamic studies too invasive, too expensive, and not predictive of treatment outcome [8] [9] [10] .
Our group has developed a totally noninvasive pressure-flow urodynamic system based on the concept of transperineal Doppler ultrasonography [11, 12] , and has proven that flow velocity can be noninvasively measured at any point along the urethra, and the functional crosssectional area of the prostatic urethra was significantly smaller in the obstructed group than in the unobstructed group [13] . The aim of this study was to verify the change in velocity-flow parameters before and after · 1 -blocker treatment for LUTS. In addition, we wanted to find the best velocity-flow-related parameter, which could possibly be used to predict the clinical outcome of LUTS.
Patients and Methods
Twenty-two consecutive patients with BPH (estimated prostatic volume 1 20 g using transabdominal ultrasonography) were treated with an · 1 -blocker and underwent velocity-flow video urodynamics before and 4 weeks after treatment. The velocity-flow video urodynamics are described in detail below. All patients also underwent standard diagnostic evaluation consisting of history (including the International Prostate Symptom Score, IPSS) and uroflowmetry. All patients were administered a nonselective · 1 -blocker, urapidil (30 mg twice daily), and were considered neurologically normal based on history, symptoms and physical examination. The estimation of therapeutic outcome was based on the Japanese Urological Association criteria (IPSS ratio: before/after) [14] . An IPSS ratio (before/after) of ! 0.25 was considered excellent, ! 0.5 good, ! 0.75 fair, and 1 0.75 a poor response. Written informed consent was obtained from the patients participating in this study.
Velocity-Flow Video Urodynamics
We used an ultrasonic image-directed color Doppler system (SSD-5500, Aloka), composed of a 3.75-MHz micro-convex electroprobe for this study. Subjects sat on a uroflow micturition chair. Natural micturition was observed under ultrasound monitoring. Each patient was asked to try not to strain the abdominal as much as possible in order to prevent ultrasound artifacts. Uroflow rates from the urethral meatus were measured with a rotating disc uroflow meter (DISA 2100 system: Dantec). We analyzed the uroflow data when the voided volume was 1 150 ml. This prototype system was designed to simultaneously measure both the flow velocity in the urethra by Doppler ultrasound and the flow rate by uroflowmetry. The digital uroflow data signals and the color Doppler ultrasound image were processed on a personal computer.
Data Processing
Information on Doppler shift frequencies derived from different flow velocities was converted to color-encoded data using the system software of SSD-5500. These color scale data were recorded as pictures every 0.5 s, then analyzed by custom software (API-TOOL, Contec) run on a personal computer (GL5133, Celebris) using Microsoft Windows XP. A multiple rectangle region of interest can be set in any size at any point around the bladder and the urethra. The color-coded data of 9 pixels/1 mm 2 were averaged to reduce technical artifacts. This calculation was performed every 0.5 s and flow velocity curves in the region of interest were obtained. The Doppler angle, the angle between the direction of flow and the direction of sound propagation, was also measured and angle correction was performed to detect each flow velocity vector.
Ultrasound Urodynamic Parameters
As in previous studies on the color-flow Doppler images, two rectangular sample areas (1 cm 2 ) were set to cover the distal prostatic urethra just above the external urethral sphincter (S 1 ) and the sphincteric urethra below S 1 (S 2 ; fig. 1 ). The maximum flow velocities at the Watanabe/Yokoyama/Ozawa/Nishiguchi/ Nose/Kumon distal prostatic urethra just above the external urethral sphincter (V 1 ) and the sphincteric urethra (V 2 ) were determined for each voiding from the flow velocity curve and displayed on the ultrasound monitor. The velocity ratio (VR) is calculated from V 1 /V 2 . The functional cross-sectional areas of the distal prostatic urethra just above the urethral sphincter (A 1 ) and the sphincteric urethra (A 2 ) were determined by dividing the maximum flow rate (Q max ) measured by uroflowmetry by the flow velocity (V 1 or V 2 ) measured by Doppler ultrasound. All parameters were automatically calculated and indicated on the graphs in the computer monitor.
Statistical Data Analysis
Statistical analysis was done using the Wilcoxon matched pairs signed rank test. A probability level of ! 0.05 was considered significant. Spearman's rank correlation coefficient rho was computed for all the parameters obtained from ultrasound urodynamics against IPSS ratio. p values of ! 0.05 were considered significant. 
Results
The mean age was 68.6 B 8.2 years, and prostatic volume was 29.9 B 8.8 cm 3 . Figure 2 illustrates the velocity flow urodynamic study of a patient with BPH before · 1 -blocker treatment. All 22 patients were cooperative for this examination. The Doppler ultrasound urodynamic parameters, IPSS and quality of life index before and after treatment are summarized in table 1. Although the mean values of maximum flow velocities of the prostatic urethra just above the external sphincter (V 1 ) significantly decreased from 52.6 to 24.6 cm/s (53% reduction) after · 1 -blocker administration, those of the maximum flow velocities of the sphincteric urethra (V 2 ) did not demon- Spearman's rho = Spearman's rank correlation coefficient with change in IPSS ratio.
Watanabe/Yokoyama/Ozawa/Nishiguchi/ Nose/Kumon strate a significant change. The mean value of VR, which is calculated from V 1 /V 2 , significantly decreased from 1.53 to 0.66 (57% reduction) after treatment (table 1) . VR changed to !1.0 in all patients after the · 1 -blocker treatment. The correlation between the IPSS ratio and velocity flow parameters of baseline is shown in table 2. V 2 and VR correlated significantly with the IPSS ratio, and with Spearman's rho of 0.584 and 0.577, respectively (p = 0.008). In particular, V 2 correlated the best with the change in IPSS before and after · 1 -blocker therapy. The functional cross-sectional areas of the distal prostatic urethra were just above. In the patients whose V 2 was 150 cm/s, subjective improvement was poor (table 2) [14] .
Discussion
BPH may cause bladder outlet obstruction (BOO) by 2 different mechanisms. One is a static compression of the urethra by the prostatic adenoma, and the other is a dynamic · 1 -adrenoceptor-mediated sympathetic stimulation of the prostatic smooth muscle [3] . Alpha-1-blockers relax the prostatic smooth muscle and induce the symptomatic improvement in LUTS. The success of treatment for BPH is usual defined by improvement in uroflowmetry parameters and symptoms [15] . It is still unclear whether · 1 -blocker treatment can relieve BOO [16, 17] .
We have developed a method of totally noninvasive color Doppler urodynamic evaluation in combination with standard uroflowmetry [11, 12] and also demonstrated the intra-and inter-rater reliability of this system [18] . Flow velocity in the distal prostatic urethra (V 1 ) and in the sphincteric urethra (V 2 ) were measured and a variety of velocity-flow-related parameters were developed [13] . Since VR and A 1 had a good correlation with the pressure-flow parameters (URA and Abrams-Griffith, AG, number) obtained from independent conventional pressure-flow studies, noninvasive pressure-flow-like urodynamic evaluation based on Doppler ultrasound proved to have a clear potential for diagnosing BOO [12] . So far, pressure flow study has been the gold standard for the diagnosis of BOO. However, it is an invasive procedure. For Doppler ultrasound urodynamics it is not necessary to insert a catheter and is therefore less invasive. The cost of this technique is almost same as a conventional pressure flow study. If this system is an alternative method, it would be more beneficial for patients. In this study, we examined whether the velocity-flow parameters could prove relief to the prostatic urethra (BOO) after · 1 -blocker treatment, and we sought the best velocity-flow-related parameter to allow prediction of improvement of LUTS following BPH treatment.
Regarding the change in parameters, V 1 , A 1 and VR were significantly altered after · 1 -blocker treatment. The best Doppler signal can be obtained in the distal prostatic urethra, the region measured by V 1 despite the different flow conditions. The decrease in V 1 and increase in A 1 after · 1 -blocker treatment suggest that relaxation of the prostatic urethra caused the cross-sectional area of the prostatic urethra to increase during voiding. The cause of the unchanged V 2 value indicates that relaxation of sphincteric urethra was smaller than that of the prostatic urethra.
In our previous study, we developed VR to compare the maximum velocity at the distal prostatic urethra with that at the membranous urethra. We found that all men with a VR exceeding 1.6 were obstructed by pressure-flow criteria (AG number 140) and, similarly, all men except for 1 with a VR below 1.1 were equivocal or unobstructed (AG number ^40) [13] . After the administration of · 1 -blockers, VR improved from 1.53 to 0.66. The decrease in VR suggests that BOO has improved after · 1 -blocker treatment. The symptoms and the velocity-flow parameters improved after treatment in all · 1 -blocker groups. We are convinced that Doppler ultrasound urodynamics can evaluate the effect of · 1 -blockers.
V 2 correlated best with changes in IPSS before and after the treatment, with Spearman's rho of 0.584. All 7 patients who had a higher value of V 2 (50 cm/s or higher) before the treatment showed no clear response in terms of symptomatic improvement. A high V 2 value (velocity of sphincteric urethra) might indicate poor relaxation of the urethral sphincter, which indicates the existence of an occult neurogenic disorder. Further studies are required to clarify the possibility of predicting the clinical outcome in terms of an improvement in BOO including a comparison with a standard urodynamics.
